论文部分内容阅读
目的:探析临床上早期采用通窍醒脑方法治疗老年缺氧缺血性脑病的临床疗效。方法:本研究选择我院2000年2月到2011年10月期间收治的120例缺氧缺血脑病老年患者为研究对象,将其随机分为两组,对照组60例患者行临床常规治疗,治疗组60例患者在治疗组基础上给予脑活素以及复方丹参注射液,对比分析两组临床疗效。结果:治疗组患者治疗后显效率和总有效率均高于对照组(P<0.05);治疗组患者经过1疗程治疗后NBNA评分均明显优于对照组患者(P<0.05),两组患者不良反应发生率均较低,比较差异不具有统计学意义(P>0.05)。结论:临床上采用脑活素联合复方丹参注射液进行早期通窍醒脑方法治疗老年缺氧缺血性脑病的临床疗效显著,安全性良好,值得在临床上广泛推广和应用。
Objective: To investigate the clinical effect of Tongqiao Xingnao method in the treatment of senile hypoxic-ischemic encephalopathy. Methods: 120 elderly patients with hypoxic-ischemic encephalopathy admitted to our hospital from February 2000 to October 2011 were selected as study subjects and randomly divided into two groups. The control group of 60 patients underwent routine clinical treatment, Sixty patients in the treatment group were given cerebrolysin and compound Danshen injection on the basis of the treatment group, and the clinical efficacy was compared between the two groups. Results: The effective rate and total effective rate of the treatment group were significantly higher than those of the control group (P <0.05). After one course of treatment, the NBNA score of the treatment group was significantly better than that of the control group (P <0.05) The incidence of adverse reactions were low, the difference was not statistically significant (P> 0.05). Conclusion: The clinical efficacy of cerebrolysin combined with compound Salvia miltiorrhiza injection for the treatment of senile hypoxic-ischemic encephalopathy by early Tongqiao Xingnao method is significant and safe. It is worth widely popularized and applied clinically.